Mainieri F, La Bella S, Chiarelli F. Hyperlipidemia and cardiovascular risk in children and adolescents. Biomedicines. 2023;11(3):809. https://doi.org/10.3390/biomedicines11030809.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Navar-Boggan AM, Peterson ED, D’Agostino Sr RB, Neely B, Sniderman AD, Pencina MJ. Hyperlipidemia in early adulthood increases long-term risk of coronary heart disease. Circulation. 2015;131(5):451–8. https://doi.org/10.1161/CIRCULATIONAHA.114.012477.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cho SMJ, Lee H, Lee H-H, Baek J, Heo JE, Joo HJ, Hong SJ, Kim HC. Dyslipidemia fact sheets in Korea 2020: an analysis of nationwide population-based data. J Lipid Atheroscler. 2021;10(2):202. https://doi.org/10.12997/jla.2021.10.2.202.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Febriani D. The effect of lifestyle on hypercholesterolemia. Open Public Health J. 2018;11(1). https://doi.org/10.2174/1874944501811010526.

Pirillo A, Casula M, Olmastroni E, Norata GD, Catapano AL. Global epidemiology of dyslipidaemias. Nat Rev Cardiol. 2021;18(10):689–700. https://doi.org/10.1038/s41569-021-00541-4.

Article  CAS  PubMed  Google Scholar 

Kopp W. How Western diet and lifestyle drive the pandemic of obesity and civilization diseases. Diabetes Metab Syndr Obes. 2019;2221–36. https://doi.org/10.2147/DMSO.S216791.

Berberich AJ, Hegele RA. A modern approach to dyslipidemia. Endocr Rev. 2022;43(4):611–53. https://doi.org/10.1210/endrev/bnab037.

Article  PubMed  Google Scholar 

Choi R, Lee SG, Lee EH. Effect of adding Apolipoprotein B testing on the prevalence of dyslipidemia and risk of cardiovascular disease in the Korean adult population. Metabolites. 2024;14(3):169. https://doi.org/10.3390/metabo14030169.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jin E-S, Shim J-S, Kim SE, Bae JH, Kang S, Won JC, Shin M-J, Jin HY, Moon J, Lee H. Dyslipidemia fact sheet in South Korea, 2022. Diabetes Metab J. 2023;47(5):632–42. https://doi.org/10.4093/dmj.2023.0135.

Article  PubMed  PubMed Central  Google Scholar 

Tiwari V, Khokhar M. Mechanism of action of anti-hypercholesterolemia drugs and their resistance. Eur J Pharmacol. 2014;741:156–70. https://doi.org/10.1016/j.ejphar.2014.07.048.

Article  CAS  PubMed  Google Scholar 

Banach M, Penson PE. Statins and LDL-C in secondary prevention—So much progress, so Far to go. JAMA Netw Open. 2020;3(11):e2025675–2025675. https://doi.org/10.1001/jamanetworkopen.2020.25675.

Article  PubMed  Google Scholar 

Coppinger C, Movahed MR, Azemawah V, Peyton L, Gregory J, Hashemzadeh M. A comprehensive review of PCSK9 inhibitors. J Cardiovas Pharmacol Ther. 2022;27:10742484221100107. https://doi.org/10.1177/10742484221100107.

Article  CAS  Google Scholar 

Savarese G, De Ferrari GM, Rosano GM, Perrone-Filardi P. Safety and efficacy of ezetimibe: a meta-analysis. Int J Cardiol. 2015;201:247–52. https://doi.org/10.1016/j.ijcard.2015.08.103.

Article  PubMed  Google Scholar 

Bruckert E, Labreuche J, Deplanque D, Touboul P-J, Amarenco P. Fibrates effect on cardiovascular risk is greater in patients with high triglyceride levels or atherogenic dyslipidemia profile: a systematic review and meta-analysis. J Cardiovasc Pharmacol. 2011;57(2):267–72. https://doi.org/10.1097/FJC.0b013e318202709f.

Article  CAS  PubMed  Google Scholar 

Schachter M. Strategies for modifying high-density lipoprotein cholesterol: a role for nicotinic acid. Cardiovasc Drugs Ther. 2005;19(6):415–22. https://doi.org/10.1007/s10557-005-5685-0.

Article  CAS  PubMed  Google Scholar 

Feng Y, Li Q, Ou G, Yang M, Du L. Bile acid sequestrants: A review of mechanism and design. J Pharm Pharmacol. 2021;73(7):855–61. https://doi.org/10.1093/jpp/rgab002.

Article  PubMed  Google Scholar 

de Ferranti SD, Milliren CE, Denhoff ER, Steltz SK, Selamet Tierney ES, Feldman HA, Osganian SK. Using high-dose omega-3 fatty acid supplements to lower triglyceride levels in 10-to 19-year-olds. Clin Pediatr. 2014;53(5):428–38. https://doi.org/10.1177/0009922814528032.

Article  Google Scholar 

Lillich FF, Goorani S, Proschak E, Imig JD. Multi-target drugs to treat metabolic diseases. Polypharmacology. 2025;175–91. https://doi.org/10.1002/9781394182862.ch13.

Yan J, Liu M, Yang D, Zhang Y, An F. Efficacy and safety of omega-3 fatty acids in the prevention of cardiovascular disease: a systematic review and meta-analysis. Cardiovasc Drugs Ther. 2024;38(4):799–817. https://doi.org/10.1007/s10557-022-07379-z.

Article  CAS  PubMed  Google Scholar 

Choi HD, Chae SM. Comparison of efficacy and safety of combination therapy with Statins and omega-3 fatty acids versus Statin monotherapy in patients with dyslipidemia: A systematic review and meta-analysis. Medicine. 2018;97(50):e13593. https://doi.org/10.1097/MD.0000000000013593.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kavanagh ON, Albadarin AB, Croker DM, Healy AM, Walker GM. Maximising success in multidrug formulation development: A review. J Control Release. 2018;283:1–19. https://doi.org/10.1016/j.jconrel.2018.05.024.

Article  CAS  PubMed  Google Scholar 

Bangalore S, Shahane A, Parkar S, Messerli FH. Compliance and fixed-dose combination therapy. Curr Hypertens Rep. 2007;9(3):184–9. https://doi.org/10.1007/s11906-007-0033-3.

Article  CAS  PubMed  Google Scholar 

Cholewski M, Tomczykowa M, Tomczyk M. A comprehensive review of chemistry, sources and bioavailability of omega-3 fatty acids. Nutrients. 2018;10(11):1662. https://doi.org/10.3390/nu10111662.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yi M, You Y, Zhang Y, Wu G, Karrar E, Zhang L, Zhang H, Jin Q, Wang X. Highly valuable fish oil: formation process, enrichment, subsequent utilization, and storage of eicosapentaenoic acid Ethyl esters. Molecules. 2023;28(2):672. https://doi.org/10.3390/molecules28020672.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tocher DR, Betancor MB, Sprague M, Olsen RE, Napier JA. Omega-3 long-chain polyunsaturated fatty acids, EPA and DHA: bridging the gap between supply and demand. Nutrients. 2019;11(1):89. https://doi.org/10.3390/nu11010089.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Oliver L, Dietrich T, Marañón I, Villarán MC, Barrio RJ. Producing omega-3 polyunsaturated fatty acids: A review of sustainable sources and future trends for the EPA and DHA market. Resources. 2020;9(12):148. https://doi.org/10.3390/resources9120148.

Article  Google Scholar 

Balakrishnan J, Kannan S, Govindasamy A. Structured form of DHA prevents neurodegenerative disorders: A better insight into the pathophysiology and the mechanism of DHA transport to the brain. Nutr Res. 2021;85:119–34. https://doi.org/10.1016/j.nutres.2020.12.003.

Article  CAS  PubMed  Google Scholar 

Mason RP, Libby P, Bhatt DL. Emerging mechanisms of cardiovascular protection for the omega-3 fatty acid eicosapentaenoic acid. Arterioscler Thromb Vasc Biol. 2020;40(5):1135–47. https://doi.org/10.1161/ATVBAHA.119.313286.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Von Schacky C. A review of omega-3 Ethyl esters for cardiovascular prevention and treatment of increased blood triglyceride levels. Vasc Health Risk Manag. 2006;2(3):251–62. https://doi.org/10.2147/vhrm.s23251.

Article  Google Scholar 

Toth PP, Chapman MJ, Parhofer KG, Nelson JR. Differentiating EPA from EPA/DHA in cardiovascular risk reduction. Am Heart J Plus. 2022;17:100148. https://doi.org/10.1016/j.ahjo.2022.100148.

Article  PubMed  PubMed Central  Google Scholar